These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7725641)

  • 21. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Organ-specific autoimmune diseases. 2) Type I and insulin resistance B type diabetes].
    Hirata Y
    Nihon Rinsho; 1988 Apr; 46(4):901-6. PubMed ID: 3043049
    [No Abstract]   [Full Text] [Related]  

  • 22. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative effects of chronic inflammatory periodontal disease on diabetes mellitus.
    Nishimura F; Kono T; Fujimoto C; Iwamoto Y; Murayama Y
    J Int Acad Periodontol; 2000 Apr; 2(2):49-55. PubMed ID: 12666961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-insulin antibodies in children with diabetes mellitus].
    Puskás G; Lukács E; Indig B
    Pediatria (Bucur); 1970; 19(3):221-6. PubMed ID: 5453793
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of biological markers in etiopathogenesis of juvenile diabetes--reviewing the role of insulin antibodies.
    Vlaski J; Stefan S; Katanić D; Vukadinović I; Babić L
    Med Pregl; 1998; 51(5-6):221-7. PubMed ID: 9720347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological aspects of diabetes mellitus in children].
    Popa I; Deutsch G; Oţetea G; Schmidt-Georoceanu A; Man I; Bergel E
    Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(1):63-72. PubMed ID: 6808644
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin resistance: pathophysiology, diagnosis, and therapeutic implications.
    Grunfeld C
    Spec Top Endocrinol Metab; 1984; 6():193-240. PubMed ID: 6395415
    [No Abstract]   [Full Text] [Related]  

  • 30. [The radio-immunoelectrophoretic method in evaluation of anti-insulin antibodies in diabetes mellitus].
    D'Onofrio F; Toorella R; Sgambato S
    Folia Allergol (Roma); 1967; 14(6):571-8. PubMed ID: 5583590
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The activity of circulating insulin antibodies in juvenile diabetics].
    Hürter P; Kühnau J
    Helv Paediatr Acta; 1970 Apr; 25(2):154-64. PubMed ID: 5463227
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin resistance.
    Magyar I
    Acta Med Acad Sci Hung; 1975; 32(3-4):301-9. PubMed ID: 1235447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy.
    Matsuyoshi A; Shimoda S; Tsuruzoe K; Taketa K; Chirioka T; Sakamoto F; Sakakida M; Miyamura N; Araki E
    Diabetes Res Clin Pract; 2006 Jun; 72(3):238-43. PubMed ID: 16439034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The accelerator hypothesis: insulin resistance as the central cause of type 1 and type 2 diabetes.
    Booker C
    Int J Obes (Lond); 2010 Jan; 34(1):210-1; author reply 212. PubMed ID: 19844208
    [No Abstract]   [Full Text] [Related]  

  • 36. The potential biological mechanisms of arsenic-induced diabetes mellitus.
    Tseng CH
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
    Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
    Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible mechanisms of diabetic fetopathy.
    Poletaev AB; Gnedenko BB; Makarova AA; Krasnopolsky VI; Budykina TS; Petrukhin VA; Morozov SG
    Hum Antibodies; 2000; 9(4):189-97. PubMed ID: 11341172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of insulin antibodies in insulin-treated diabetic patients.
    Van Haeften TW
    Diabetes Care; 1989 Oct; 12(9):641-8. PubMed ID: 2676431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.